Peter S Morris
Overview
Explore the profile of Peter S Morris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
1832
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McCallum G, Byrnes C, Morris P, Grimwood K, Marsh R, Chatfield M, et al.
BMJ Open
. 2025 Feb;
15(2):e097455.
PMID: 39909513
Introduction: Acute lower respiratory infections (ALRIs) remain the leading causes of repeated hospitalisations among young disadvantaged Australian and New Zealand First Nations and Timorese children. Severe (hospitalised) and recurrent ALRIs...
2.
Kok H, McCallum G, Yerkovich S, Grimwood K, Fong S, Nathan A, et al.
Pediatr Infect Dis J
. 2024 Jun;
43(9):872-879.
PMID: 38830139
Background: Pediatric community-acquired pneumonia (CAP) can lead to long-term respiratory sequelae, including bronchiectasis. We determined if an extended (13-14 days) versus standard (5-6 days) antibiotic course improves long-term outcomes in...
3.
Chang A, Yerkovich S, Baines K, Burr L, Champion A, Chatfield M, et al.
BMJ Open Respir Res
. 2024 May;
11(1).
PMID: 38719503
Introduction: Bronchiectasis is a worldwide chronic lung disorder where exacerbations are common. It affects people of all ages, but especially Indigenous populations in high-income nations. Despite being a major contributor...
4.
Chang A, Dharmage S, Marchant J, McCallum G, Morris P, Schultz A, et al.
Arch Bronconeumol
. 2024 Mar;
60(6):364-373.
PMID: 38548577
Bronchiectasis, particularly in children, is an increasingly recognised yet neglected chronic lung disorder affecting individuals in both low-to-middle and high-income countries. It has a high disease burden and there is...
5.
Mandal P, Cleanthous A, Rigas V, Kleinecke M, Lawrence K, Leach A, et al.
Microbiol Resour Announc
. 2024 Jan;
13(2):e0107123.
PMID: 38275301
are opportunistic pathogens typically associated with genitourinary infections. Here, we report the complete genome for an isolate recovered from ear discharge of a child with chronic suppurative otitis media (strain...
6.
Binks M, Bleakley A, Pizzutto S, Lamberth M, Powell V, Nelson J, et al.
BMJ Open Respir Res
. 2023 Aug;
10(1).
PMID: 37586777
Introduction: Globally, acute respiratory infections (ARIs) are a leading cause of childhood morbidity and mortality. While ARI-related mortality is low in Australia, First Nations infants are hospitalised with ARIs up...
7.
Bowman-Derrick S, Harris T, Beissbarth J, Kleinecke M, Lawrence K, Wozniak T, et al.
Pediatr Investig
. 2023 Mar;
7(1):13-22.
PMID: 36967743
Importance: In remote communities of the Northern Territory, Australia, children experience high rates of otitis media (OM), commonly caused by non-typeable (NTHi). Few data exist on antibiotic susceptibility of NTHi...
8.
Francis J, Fairhurst H, Yan J, Monteiro A, Lee A, Maurays J, et al.
J Am Soc Echocardiogr
. 2023 Feb;
36(7):733-745.
PMID: 36806665
Background: Early detection of rheumatic heart disease (RHD) through echocardiographic screening can facilitate early access to effective treatment, which reduces the risk for progression. Accurate, feasible approaches to echocardiographic screening...
9.
Vicendese D, Yerkovich S, Grimwood K, Valery P, Byrnes C, Morris P, et al.
Chest
. 2022 Aug;
163(1):52-63.
PMID: 36030839
Background: Following evidence from randomized controlled trials, patients with bronchiectasis unrelated to cystic fibrosis receive long-term azithromycin to reduce acute respiratory exacerbations. However, the period when azithromycin is effective and...
10.
Chang A, Morgan L, Duncan E, Chatfield M, Schultz A, Leo P, et al.
BMJ Open Respir Res
. 2022 May;
9(1).
PMID: 35534039
Introduction: Primary ciliary dyskinesia (PCD) is a rare, progressive, inherited ciliopathic disorder, which is incurable and frequently complicated by the development of bronchiectasis. There are few randomised controlled trials (RCTs)...